文献速递骨显像与常规 SPECT

[99mTc]Tc-NTP 15-5,一种新型蛋白聚糖示踪剂用于关节软骨功能成像:I期(CARSPECT)

[99mTc]Tc-NTP 15 - 5, a new proteoglycan tracer for functional imaging of joint cartilage: phase I (CARSPECT).
PubMed 文献 · EJNMMI Res · 2025-09-26

本研究为I期试验(CARSPECT:NCT04481230),纳入5例单侧膝骨关节炎或接受激素治疗致软骨病的乳腺癌患者,按5、10、15 MBq/kg递增活性注射[99mTc]Tc-NTP 15-5,未报告重大毒性,15 MBq/kg注射后2小时关节摄取中位率80.6%,SPECT-CT软骨信噪比2小时30分后大于3,结论支持该示踪剂在注射后2小时、15 MBq/kg下用于人体软骨功能成像的可用性与准确性。

要点

  • 5例患者按5、10、15 MBq/kg递增活性注射[99mTc]Tc-NTP 15-5,未报告重大毒性。
  • 15 MBq/kg时,注射后2小时全身平面显像关节摄取高于骨干的中位率为80.6%。
  • SPECT-CT上软骨信噪比在注射后2小时30分起大于3,结论支持15 MBq/kg、注射后2小时成像。

核心结论

  • 本研究确认[99mTc]Tc-NTP 15-5在注射后2小时、15 MBq/kg下用于人体软骨功能成像的可用性与准确性。

研究设计与样本

  • I期试验(CARSPECT:NCT04481230),2020年11月至2022年6月纳入5例单侧膝骨关节炎或接受激素治疗致软骨病的乳腺癌患者,按5、10、15 MBq/kg递增活性注射[99mTc]Tc-NTP 15-5。

主要发现

  • 按NCICTC 4.0量表未报告重大毒性。
  • 15 MBq/kg时,全身平面显像关节摄取高于骨干的中位率在注射后2小时为80.6%(80.60-85.45),并随时间增加。
  • SPECT-CT上软骨相对于肌肉本底的信噪比在注射后2小时30分起大于3。
  • 注射后1小时00分至6小时30分的摄取随时间演变可区分软骨与汇总蛋白聚糖结构及本底(p < 0.001)、软骨与韧带+肌腱(所有检查时间点p < 0.001),并在注射后1小时区分软骨与滑囊(p < 0.05)。
  • 药代动力学、生物分布与剂量学与临床前研究一致。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: [99mTc]Tc-NTP 15 - 5 showed affinity for joint cartilage proteoglycans on preclinical studies but has not been tested in humans. This phase I trial (CARPECT: NCT04481230) aims to define the optimal of [99mTc]Tc-NTP 15 - 5 injected activity to obtain the best visual contrast of cartilage, without toxicity. Quantitative analyses of cartilage, periarticular uptakes, biodistribution, pharmacokinetic and dosimetry of this new tracer were also studied. RESULTS: Between November 2020 and June 2022, five patients with unilateral knee osteoarthritis or breast cancer treated with hormonal therapy inducing cartilage disease were injected with [99mTc]Tc-NTP 15 - 5, at increasing activity levels: 5, 10 and 15 MBq/kg. No major toxicity was reported, according to NCICTC 4.0 scale. With an activity of 15 MBq/Kg, the median rate of joint uptakes higher than diaphysis' one on whole body planar scintigraphy was 80.6% (80.60-85.45) at 2 h p.i. and increased with time. S/N ratio with muscular background measured on SPECT-CT was superior to 3 from 2h30 p.i for cartilage. Uptake evolution depending on time from 1h00 to 6h30 p.i. permitted to discriminate cartilage and pooled proteoglycan structures from background and cartilage from ligaments + tendons for all examination times (p < 0.001), and cartilage from bursa at 1 h p.i. (p < 0.05). Pharmacokinetic, biodistribution and dosimetry were in line with preclinical studies. CONCLUSIONS: This study confirms the usability and accuracy of [99mTc]Tc-NTP 15 - 5 for cartilage human functional imaging 2 h after injection, at 15 MBq/kg. TRIAL REGISTRATION: Clinicaltrials.gov: NCT04481230. https://clinicaltrials.gov/ct2/show/NCT04481230 . Registration date: November, 12th, 2020.

来源:EJNMMI Res,查看原文。版权归原作者所有。

引用

  1. Chanchou M, Thivat E, Mathieu S, et al. [99mTc]Tc-NTP 15 - 5, a new proteoglycan tracer for functional imaging of joint cartilage: phase I (CARSPECT). EJNMMI Res. 2025. PMID: 41003883. doi:10.1186/s13550-025-01318-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。